Exclusive special offer and discount title banner vector image

INDIA MULTIPLEX ASSAY MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

India Multiplex Assay Market by Product and Service (Reagents and Consumables, Instruments and Accessories, Software and Services) Market by Type (Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Types) Market by Application (Research and Development, Clinical Diagnostics, Companion Diagnostics) Market by Technology (Multiplex Protein Microarray, Multiplex Pcr, Other Technologies) Market by End-user (Pharmaceutical & Biotechnology Companies, Research Institutes, Clinical Laboratories, Hospitals)


MARKET OVERVIEW

The India multiplex assay market is projected to register a CAGR of 9.58% during the forecast period, 2024-2032, and is predicted to garner a revenue of $311.41 million by 2032.

Improvements in healthcare infrastructure, along with a surge in healthcare reforms and expenditures in India, are poised to propel the India multiplex assay market forward. The country’s rapidly expanding population and enhancements in healthcare infrastructure are pivotal growth drivers for the market. Projections indicate that India’s total population is anticipated to surpass 1.7 billion by 2050. With the continuous growth of India’s aging population, the demand for healthcare services is expected to escalate accordingly.

Government backing in India for the advancement of the drug discovery and development market primarily revolves around the purchasing power parity model. The Indian government actively supports private entrepreneurship by assisting private biotech and pharmaceutical firms in their endeavors through collaborative research, financial aid, and grants.

India Multiplex Assay Market

To Know More About This Report, Request a Free Sample Copy

Spearheaded by the Department of Science and Technology, government initiatives promoting research and development in the country have significantly benefitted the healthcare and pharmaceutical sectors. Additionally, government agencies collaborate with various national-level research institutes and universities across India to further these objectives.

The India multiplex assay market segmentation includes product and service, type, end-user, technology, and application. The product and service segment includes reagents and consumables, instruments and accessories, and software and services.

The segment concerning instruments and accessories encompasses various tools used in multiplex assays, including analyzers and related accessories. These accessories can be either reusable or disposable, with healthcare and research institutions often favoring disposable options to reduce ongoing costs associated with cleaning and sterilization.

Furthermore, technologically advanced multiplex instruments are utilized for assays involving nucleic acids and proteins. Among these, the FLEXMAP 3D, offered by Luminex Corporation, is distinguished as a highly advanced and versatile platform. It offers rapid read times, increased compatibility, and seamless integration. Additionally, multiplexing analyzers such as the Luminex FLEXMAP 3D utilize lasers and photomultiplier tubes to detect and measure multiple analytes simultaneously, enabling high-throughput screening that is particularly valuable in both research and clinical diagnostics.

Accessories essential for multiplex assays include sheath fluid, calibration kits, and performance verification kits, all of which are critical for ensuring the accuracy and reliability of results. Moreover, disposable accessories like pipette tips and microplates are commonly used to prevent cross-contamination and reduce the need for sterilization, especially in clinical settings where maintaining sterility is paramount.

Some of the eminent players in the India multiplex assay market are Qiagen NV, Illumina Inc, Siemens Healthineers AG, etc.

Qiagen NV specializes in sample and assay technologies, offering a wide range of consumable products, such as kits, as well as various instruments and automation systems. Their sample technologies are designed to extract and purify specific molecules from biological samples, while their assay technologies enable the analysis and interpretation of genomic information contained within these molecules. Additionally, Qiagen provides bioinformatics solutions and automated systems that streamline laboratory workflows across diverse applications.

With a global presence spanning more than 35 offices across 25 countries, Qiagen delivers molecular technologies in the form of kits for both general and targeted analyses. The company boasts a comprehensive portfolio of over 500 products, catering to a broad spectrum of laboratory requirements. It is headquartered in Hilden, Germany.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast Units

Revenue ($ Million)

Segments Analyzed
Product and Service, Type, End-User, Technology, and Application
Countries AnalyzedIndia
Companies AnalyzedAgilent Technologies Inc, Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Qiagen NV, Siemens Healthineers AG, Thermo Fisher Scientific Inc
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS 
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
    6. MAJOR MARKET FINDINGS
      1. SOFTWARE AND SERVICES SECTOR EMERGES AS THE RAPIDLY EXPANDING PRODUCT & SERVICE SEGMENT
      2. PROTEIN-BASED MULTIPLEX ASSAY IS THE HIGHEST REVENUE-GENERATING TYPE
      3. RESEARCH & DEVELOPMENT APPLICATIONS DOMINATE MARKET SHARE
      4. MULTIPLEX PCR TECHNOLOGY DEMONSTRATES FASTER GROWTH
      5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE MAJOR USERS OF MULTIPLEX ASSAYS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. ESCALATING INCIDENCE OF CHRONIC DISEASES
      2. GROWING PREFERENCE FOR MULTIPLEX ASSAYS OVER CONVENTIONAL APPROACHES
      3. INCREASING ACCEPTANCE OF PERSONALIZED MEDICINE
    2. KEY RESTRAINTS
      1. OVERCOMING THE DIFFICULTY OF ESTABLISHING SUFFICIENT ASSAY RANGE
      2. CHALLENGES ASSOCIATED WITH CROSS-REACTIVITY AND ASSAY INTERFERENCE
      3. SHORTAGE OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. RISING DRUG DISCOVERY ENDEAVORS
      2. PROGRESS IN ASSAY PLATFORM TECHNOLOGY
      3. RAPID EXPANSION OF COMPANION DIAGNOSTICS
    2. PESTLE ANALYSIS
      1. POLITICAL
      2. ECONOMICAL
      3. SOCIAL
      4. TECHNOLOGICAL
      5. LEGAL
      6. ENVIRONMENTAL
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. MARKET CONCENTRATION ANALYSIS
    5. KEY BUYING CRITERIA
      1. COVERAGE OF ANALYTES
      2. RAPIDITY
      3. ABILITY TO MULTIPLEX
      4. USER-FRIENDLINESS
      5. AUTOMATION POTENTIAL
    6. VALUE CHAIN ANALYSIS
      1. RESEARCH AND DEVELOPMENT (R&D)
      2. MANUFACTURING AND PRODUCTION
      3. DISTRIBUTION AND SUPPLY CHAIN
      4. CLINICAL APPLICATION AND DATA ANALYSIS
      5. MARKET RESEARCH AND COMMERCIALIZATION
  5. MARKET BY PRODUCT AND SERVICE
    1. REAGENTS AND CONSUMABLES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. INSTRUMENTS AND ACCESSORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. SOFTWARE AND SERVICES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY TYPE
    1. PROTEIN-BASED MULTIPLEX ASSAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER TYPES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY APPLICATION
    1. RESEARCH AND DEVELOPMENT
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. CLINICAL DIAGNOSTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. COMPANION DIAGNOSTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. MARKET BY TECHNOLOGY
    1. MULTIPLEX PROTEIN MICROARRAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. MULTIPLEX PCR
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER TECHNOLOGIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  9. MARKET BY END-USER
    1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. RESEARCH INSTITUTES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. CLINICAL LABORATORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. HOSPITALS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. AGILENT TECHNOLOGIES INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      2. BECTON, DICKINSON AND COMPANY (BD)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      3. BIO-RAD LABORATORIES INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      4. F. HOFFMANN-LA ROCHE LTD
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      5. ILLUMINA INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      6. QIAGEN NV
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      7. SIEMENS HEALTHINEERS AG
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      8. THERMO FISHER SCIENTIFIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – WOOD BASED PANEL

TABLE 2: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: LIST OF MERGERS & ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: MARKET CONCENTRATION ANALYSIS

FIGURE 4: KEY BUYING CRITERIA

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: INDIA MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2023

FIGURE 7: INDIA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)

FIGURE 8: INDIA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)

FIGURE 9: INDIA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: INDIA MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023

FIGURE 11: INDIA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)

FIGURE 12: INDIA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)

FIGURE 13: INDIA MULTIPLEX ASSAY MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)

FIGURE 14: INDIA MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 15: INDIA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)

FIGURE 16: INDIA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)

FIGURE 17: INDIA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)

FIGURE 18: INDIA MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2023

FIGURE 19: INDIA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)

FIGURE 20: INDIA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)

FIGURE 21: INDIA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)

FIGURE 22: INDIA MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023

FIGURE 23: INDIA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)

FIGURE 24: INDIA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)

FIGURE 25: INDIA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)

FIGURE 26: INDIA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FAQ’s